#USA #Los Angeles #3D Printing #SprintRay #EnvisionTEC

SprintRay Strengthens Its Denture 3D Printing Division Through EnvisionTEC Acquisition

In a strategic move that underscores its dominance in the dental technology arena, SprintRay has officially acquired EnvisionTEC's esteemed portfolio, which previously belonged to Desktop Health. This acquisition marks a significant expansion for SprintRay, solidifying its commitment to enhancing 3D printing solutions in the field of dentistry.

A Milestone in Dental Technology

The purchase, announced on September 2, 2025, includes a vast range of assets—patents, trademarks, inventory, and intellectual property—that EnvisionTEC has cultivated over two decades. EnvisionTEC has long been recognized as a pioneer in dental 3D printing, holding more than 200 patents that cover various 3D printing hardware and materials. This technology footprint equips SprintRay with robust tools designed to support dental professionals globally, from labs to chairside applications.

The company's offerings now encompass an array of innovative products, including the continuous digital light manufacturing (cDLM) technology, manifest in the Envision One platform, and the advanced Einstein DLP printer series. Among the materials brought into the fold is Flexcera, an FDA-cleared hybrid nanoceramic resin expertly tailored for crafting high-quality dental prosthetics.

SprintRay's Vision for the Future

"This acquisition of EnvisionTEC's dental portfolio ensures that existing customers will maintain access to the tools and support they trust," remarked Amir Mansouri, PhD, the CEO and Co-founder of SprintRay. He emphasized that the company's mission to revolutionize dentistry through accessible and reliable 3D printing technology remains unchanged.

One of the primary goals following this acquisition is to provide dedicated customer support, ensuring that EnvisionTEC and Desktop Health customers receive continued, uninterrupted assistance as they integrate these advanced solutions into their practices. Furthermore, SprintRay is committed to sustaining the production of EnvisionTEC's resins, which is crucial for maintaining workflow efficiency within dental labs.

Innovation at the Core

SprintRay aims to foster innovation in dental care by leveraging the esteemed track record of EnvisionTEC. By cross-validating select resins from both brands, they plan to enhance compatibility across platforms, thereby streamlining processes for dental labs using various printing technologies. This development will not only enrich SprintRay’s product portfolio but will also uphold the high standards of quality expected in the dental industry.

Additionally, SprintRay's enhanced position in the dental lab technology sphere is poised to set new benchmarks in 3D printing technology for lab-focused applications, driving further advancements in the market.

Conclusion

As SprintRay embarks on this transformative journey, its resolve to redefine the landscape of dentistry through advanced, efficient 3D printing solutions remains at the forefront. This acquisition stands as a testament to the company's unwavering commitment to innovation, quality, and support—a true game changer in the fast-evolving dental industry.

For more insights and to learn about how these advancements will shape the future of dental technology, visit SprintRay's official website.